// App-Quantinova.ai

P780 : Medical treatment and surgery in patients with elderly-onset inflammatory bowel disease: 3-year follow-up of Epi-IBD 2010–2011 cohorts

Researchers

Presenter

  • V Hernandez

Principal Investigators

  • E Langholz

  • D Christodoulou

  • S Turcan

  • D Valpiani

  • P L Lakatos

  • Z Vegh

  • A Goldis

  • E Belousova

  • K Ladefoged

  • G Kiudelis

  • D McNamara

  • O Shonova

  • Z Krznaric

  • F Magro

  • E S Bjornsson

  • S Almer

  • M Fumery

  • D Duricova

  • A Kievit

  • I Kaimakliotis

  • P Ellul

  • O Niewiadomski

  • M Giannotta

  • S Odes

  • N Pedersen

  • J F Dahlerup

  • R Salupere

  • R D'Inc

  • J Halfvarson

  • P Oksanen

  • N Arebi

  • K R Nielsen

  • V Andersen

  • S Shaji

  • P Munkholm

  • J Burisch

Medical Centers

  • Instituto de Investigación Sanitaria Galicia Sur. Hospital Alvaro Cunqueiro. EOXI Vigo, Gastroenterology, Vigo, Spain

  • Gentofte Hospital, Department of Medical Gastroenterology, Copenhagen, Denmark

  • University Hospital, Ioannina, 1st Division of Internal Medicine and Hepato-Gastroenterology Unit, Ioannina, Greece

  • State University of Medicine and Pharmacy of the Republic of Moldova, Chisinau, Moldova, Republic of

  • Morgagni Hospital, Gastroenterology and Digestive Endoscopy, Forli, Italy

  • Semmelweis University, nd Department of Pathology, Budapest, Hungary

  • University of Medicine aVictor Babes?, Clinic of Gastroenterology, Timisoara, Romania

  • Moscow Regional Research and Clinical Institute (MONIKI), Department of Endocrine Surgery, Russian Federation

  • Dronning Ingrids Hospital, Medical department, Nuuk, Greenland,

  • Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania

  • Adelaide and Meath Hospital, Gastroenterology, Dublin, Ireland

  • Hospital Ceske Budejovice, Gastroenterology Department, Ceske Budejovice, Czech Republic,

  • University Hospital Center Zagreb, Hematology, Zagreb, Croatia

  • Hospital de São João, Porto; Institute of Pharmacology and Therapeutics, Oporto Medical School and Institute for molecular and cell biology, Gastroenterology, Porto, Portugal

  • Landspitali - The National University Hospital of Iceland, Gastroenterology, Reykjavik, Iceland

  • Karolinska Institutet, GastroCentrum, Stockholm, Sweden

  • Amiens University and Hospital, Epimad Registry, Gastroenterology Unit, Amiens, France

  • Charles University, IBD Center ISCARE, Prague, Czech Republic

  • Herning Central Hospital, Herning, Denmark

  • Private practice, Nicosia, Cyprus

  • Mater Dei Hospital, Department of Gastroenterology, Tal Qroqq, Malta

  • St Vincents Hospital, Gastroenterology, Fitzroy, Australia

  • AOU Careggi, Regional Referral Center fo Inflammatory Bowel Disease - Gastroenterology 1 Division, Florence, Italy

  • Soroka Medical Center and Ben Gurion University of the Negev, Department of Gastroenterology and Hepatology, Beer Sheva, Israel

  • Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark

  • Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark

  • Tartu University Hospital, Division of Endocrinology and Gastroenterology, Tartu, Estonia

  • Azienda Ospedaliera di Paodva, Department of Sugery, Oncology and Gastroenterology, Padua, Italy

  • Faculty of Medicine and Health, Gastroenterology, Orebro, Sweden

  • Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland

  • St. Mark's Hospital, Imperial College London, Gastroenterology, London, UK

  • The National Hospital of the Faroe Islands, Medical Department, Thorshavn, Faroe Islands

  • Regional Hospital of Viborg, Medical Department, Viborg, Denmark

  • Hull and East Yorkshire NHS Trust, IBD Unit, Hull, UK

  • North Zealand Hospital, Department of Gastroenterology, Frederikssund, Denmark

Locations

  • Spain

  • Denmark

  • Greece

  • Republic of South Korea

  • Italy

  • Hungary

  • Romania

  • Russia

  • Greenland

  • Lithuania

  • Ireland

  • Czech Republic

  • Croatia

  • Portugal

  • Iceland

  • Sweden

  • France

  • Cyprus

  • Malta

  • Australia

  • Israel

  • Estonia

  • Finland

  • United Kingdom

  • Faroe Islands

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved